tlag‽ [Regulatives / Guidelines]

posted by nobody – 2017-12-21 16:18 (1991 d 12:57 ago) – Posting: # 18076
Views: 7,078

...somebody had a look at the ADRs (mostly upper GI-tract-related, therefore the gastroresistant formulation) and said, hey, we have to "quantitate" the quality of the gastroresistant part of the formulations. Let's do tlag!

afaik the SmPC recommends application in fed state, due to better tolerability. The EMA guideline gives no recommendation re. fasted/fed?!

On the other hand: Modified release with one single-dose study only?

Kindest regards, nobody

Complete thread:

UA Flag
 Admin contact
22,616 posts in 4,740 threads, 1,613 registered users;
31 visitors (0 registered, 31 guests [including 22 identified bots]).
Forum time: 06:16 CEST (Europe/Vienna)

Mediocrity is a fungus of the mind.    Reif Larsen

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz